The professor of medicine and epidemiology at BUSM and SPH was awarded AHA Population Research Prize for findings of genetic flaws and other causes contributing to heart, vascular diseases.
A novel molecular pathway needed to regulate kidney podocytes has been discovered.
Michael Silverstein, MD, has been appointed to the U.S. Preventive Services Task Force as one of its newest members.
The new development will impact how resources are utilized and how quickly results are conveyed to law enforcement.
Researchers have identified a new pathway and with it a protein, BRD4, necessary for breast cancer cells to spread. The findings, which appear in the journal Cancer Research, may provide a new target to suppress breast cancer metastasis. Triple-negative breast cancer is considered the worst subgroup of breast cancer. It is highly aggressive and responds […]
Two of the NIH awards, totaling $5 million, will support a new National Heart, Lung, and Blood Institute initiative aimed to develop stem cell-based treatments for heart, lung and blood diseases.
For the first time, researchers have shown that using MRIs can effectively identify bone marrow cancer (myelofibrosis) in an experimental model. The findings may change the way this disease is diagnosed.
The fifth annual BUMC/VA Boston Healthcare System Joining Forces conference was held on Tuesday, Nov. 8 – Election Day – and just three days before Veteran’s Day. Part of a national initiative founded by first lady Michelle Obama and Dr. Jill Biden that focuses on wellness, education and employment opportunities for service members and Veterans, […]
The findings, which appear online in the Journal of Hepatology, are important in understanding the link between these diseases, which continues to be one of the major causes of morbidity and mortality worldwide.
Corresponding author Sabra Botch-Jones hopes that this will assist in conducting risk assessments and implementing control measures for designer drugs.